Ratings by LifeSci Capital (Rami Katkhuda)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/22/2026 | Eloxx Pharma | ELOX | New Coverage | Outperform (N/A) |
12.00 (15.60) |
30% | Details | |
| 3/26/2024 | Mineralys Therapeutics, Inc. | MLYS | Downgrade | Outperform (N/A) |
12.92 (28.26) |
118.73% | Details |
